Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial (vol 22, pg 1704, 2024)

被引：0

作者：

McBane Ii, Robert D. ^{[1
]}

Loprinzi, Charles L. ^{[2
]}

Zemla, Tyler ^{[3
]}

Tafur, Alfonso ^{[4
]}

Sanfilippo, Kristen ^{[5
]}

Liu, Jane Jijun ^{[6
]}

Garcia, David A. ^{[7
]}

Heun, James ^{[8
]}

Gundabolu, Krishna ^{[9
]}

Onitilo, Adedayo A. ^{[10
]}

Perepu, Usha ^{[11
]}

Drescher, Monic R. ^{[12
]}

Henkin, Stanislav ^{[12
]}

Houghton, Damon ^{[1
]}

Ashrani, Aneel ^{[13
]}

Billett, Henny ^{[14
]}

Mooberry, Micah J. ^{[15
]}

Mccue, Shaylene A.

Lee, Minji K. ^{[3
]}

Le-Rademacher, Jennifer G. ^{[3
]}

Wysokinski, Waldemar E. ^{[1
]}

机构：

[1] Mayo Clin, Gonda Vasc Ctr, Vasc Med Div, Rochester, MN 55905 USA

[2] Mayo Clin, Dept Med Oncol, Rochester, MN USA

[3] Mayo Clin, Clin trials & Biostat, Rochester, MN USA

[4] North Shore Univ Hlth Syst, Cardiovasc Div, Evanston, IL USA

[5] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA

[6] Illinois Canc Care, Hematol & Med Oncol, Peoria, IL USA

[7] Univ Washington, Hematol Div, Seattle, WA USA

[8] Dean Hematol & Med Oncol Grp, Madison, WI USA

[9] Univ Nebraska Med Ctr, Hematol & Med Oncol, Omaha, NE USA

[10] Marshfield Clin Fdn Med Res & Educ, Canc Care & Res Ctr, Marshfield, WI USA

[11] Univ Iowa, Holden Comprehens Canc Ctr, Hematol & Med Oncol, Iowa City, IA USA

[12] Dartmouth Hitchcock Med Ctr, Cardiovasc Med, Lebanon, NH USA

[13] Mayo Clin, Hematol Div, Rochester, MN USA

[14] Montefiore Med Ctr, Bronx, NY USA

[15] Univ North Carolina, Chapel Hill, NC USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2025年 / 23卷 / 02期

关键词：

D O I：

10.1016/j.jtha.2024.12.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：756 / 756

页数：1

共 50 条

[1] Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial
McBane II, Robert D.
Loprinzi, Charles L.
Zemla, Tyler
Tafur, Alfonso
Sanfilippo, Kristen
Liu, Jane Jijun
Garcia, David A.
Heun, James
Gundabolu, Krishna
Onitilo, Adedayo A.
Perepu, Usha
Drescher, Monic R.
Henkin, Stanislav
Houghton, Damon
Ashrani, Aneel
Billett, Henny
McCue, Shaylene A.
Lee, Minji K.
Le-Rademacher, Jennifer G.
Wysokinski, Waldemar E.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 22 (06) : 1704 - 1714
[2] Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial
McBane, Robert D., II
Loprinzi, Charles L.
Ashrani, Aneel
Lenz, Charles J.
Houghton, Damon
Zemla, Tyler
Le-Rademacher, Jennifer G.
Wysokinski, Waldemar E.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (02) : 88 - 96
[3] TREATMENT AND SECONDARY PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
Shakaryants, G. A.
Budanova, D. A.
Lobastov, K., V
Khabarova, N., V
Kirichenko, Y. Y.
Belenkov, Y. N.
KARDIOLOGIYA, 2020, 60 (03) : 71 - 79
[4] Apixaban for the treatment of venous thromboembolism in cancer patients: data from the AMPLIFY trial
Agnelli, G.
Buller, H. R.
Cohen, A.
Curto, M.
Gallus, A. S.
Pak, R.
Raskob, G. E.
Weitz, J. I.
Yamabe, T.
EUROPEAN HEART JOURNAL, 2014, 35 : 994 - 994
[5] A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
Levine, M. N.
Gu, C.
Liebman, H. A.
Escalante, C. P.
Solymoss, S.
Deitchman, D.
Ramirez, L.
Julian, J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (05) : 807 - 814
[6] Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial
Brandt, Willem
Brown, Cameron
Wang, Tzu-Fei
Tagalakis, Vicky
Shivakumar, Sudeep
Ciuffini, Leonardo A.
Mallick, Ranjeeta
Wells, S.
Carrier, Marc
THROMBOSIS RESEARCH, 2022, 216 : 8 - 10
[7] Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
Agnelli, G.
Buller, H. R.
Cohen, A.
Gallus, A. S.
Lee, T. C.
Pak, R.
Raskob, G. E.
Weitz, J. I.
Yamabe, T.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (12) : 2187 - 2191
[8] Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism (vol 193, pg 160, 2020)
Trujillo-Santos, Javier
Beroiz, Patricia
Moustafa, Fares
Alonso, Alicia
Morejon, Estrella
Lopez-Reyes, Raquel
Casado, Ignacio
Antonio Porras, Jose
Flores, Katia
Lopez-Nunez, Juan J.
Monreal, Manuel
THROMBOSIS RESEARCH, 2020, 196 : 641 - 641
[9] Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism (vol 193, pg 160, 2020)
Trujillo-Santos, Javier
Beroiz, Patricia
Moustafa, Fares
Alonso, Alicia
Morejon, Estrella
Lopez-Reyes, Raquel
Casado, Ignacio
Porras, Jose Antonio
Flores, Katia
Lopez-Nunez, Juan J.
Monreal, Manuel
THROMBOSIS RESEARCH, 2021, 208 : 233 - 233
[10] Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial
Kimpton, Miriam
Wells, Philip S.
Carrier, Marc
THROMBOSIS RESEARCH, 2018, 164 : S124 - S129

← 1 2 3 4 5 →